The invention relates to substituted (aza)indole derivatives, or pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof, as well as to pharmaceutical compositions containing them and to their use as modulators of α7 nicotinic acetylcholine receptor activity in a mammalian subject. (I)
这项发明涉及替代的(氮杂)
吲哚衍
生物,或其药学上可接受的盐、
生物活性代谢物、前药、外消旋体、对映体、二对映异构体、溶剂合物和
水合物,以及含有它们的药物组合物,以及它们作为调节哺乳动物主体中α7
尼古丁乙酰胆碱受体活性的用途。(I)